Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
Retreatment with upadacitinib after withdrawal effectively improved clinical signs and pruritus in patients with AD, with a manageable safety profile, supporting its use for long-term management of AD.
Authors
- Naoko Kanda (ORCID: https://orcid.org/0000-0003-4389-2312)
- Hidehisa Saeki (ORCID: https://orcid.org/0000-0002-1095-0355)
- Eita Fujimoto (ORCID: https://orcid.org/0009-0002-5914-3244)
- Teppei Hagino (ORCID: https://orcid.org/0000-0002-4183-9596)
Institutions
- Fujimoto Dental and Oral Surgery Clinic (JP)
- Chiba Hokusou Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1093/ced/llae410
- Citations
- 4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.14